Deepika Wadhera, Priyanka Naryal, Tripti Mishra, Jaskirat Singh, Irbinder K Bali
{"title":"Clinicohematological Profile of Pancytopenia Patients in Tertiary Care Hospital.","authors":"Deepika Wadhera, Priyanka Naryal, Tripti Mishra, Jaskirat Singh, Irbinder K Bali","doi":"10.4103/jpbs.jpbs_631_25","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pancytopenia is a common hematological problem characterized by anemia, leucopenia, and thrombocytopenia. It can be a serious and life-threatening illness.</p><p><strong>Aim: </strong>The objective of this study is to study the clinical presentation and hematological profile in pancytopenia patients.</p><p><strong>Material and methods: </strong>The prospective study was done on 50 pancytopenia patients in a tertiary care hospital and the hematological profile was studied. All the cases with hemoglobin [Hb] less than 13 gm/dL in male and female <12 g/dL, total leukocyte count [TLC] less than 4000/cumm, and platelet count less than 150,000/cumm were included in the study.</p><p><strong>Result: </strong>It was observed that the majority of the cases had hypercellular marrow [40%], 34% normocellular, and 26% hypocellular marrow. Males [52%] were affected more as compared to females [48%]. Megaloblastic erythroid hyperplasia was found to be the commonest cause for pancytopenia [40%], followed by normoblastic erythroid hyperplasia [5.71%], non-Hodgkin lymphoma [11.42%], acute leukemia [2.85%], MDS [2.85%], malaria [2.85%], hypersplenism 2.85%], lymphoid malignancy [2.85%], focal gelatinous [2.85%], AML [2.85%], megakaryocytic thrombocytopenia [2.85%], and plasma cell myeloma [2.85%].</p><p><strong>Conclusion: </strong>It was concluded that the detailed hematological investigations, a thorough clinical examination with hematological studies and bone marrow study is important for understanding the disease process and diagnosing the causes of pancytopenia.</p>","PeriodicalId":94339,"journal":{"name":"Journal of pharmacy & bioallied sciences","volume":"17 Suppl 1","pages":"S353-S356"},"PeriodicalIF":0.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12156772/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy & bioallied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_631_25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Pancytopenia is a common hematological problem characterized by anemia, leucopenia, and thrombocytopenia. It can be a serious and life-threatening illness.
Aim: The objective of this study is to study the clinical presentation and hematological profile in pancytopenia patients.
Material and methods: The prospective study was done on 50 pancytopenia patients in a tertiary care hospital and the hematological profile was studied. All the cases with hemoglobin [Hb] less than 13 gm/dL in male and female <12 g/dL, total leukocyte count [TLC] less than 4000/cumm, and platelet count less than 150,000/cumm were included in the study.
Result: It was observed that the majority of the cases had hypercellular marrow [40%], 34% normocellular, and 26% hypocellular marrow. Males [52%] were affected more as compared to females [48%]. Megaloblastic erythroid hyperplasia was found to be the commonest cause for pancytopenia [40%], followed by normoblastic erythroid hyperplasia [5.71%], non-Hodgkin lymphoma [11.42%], acute leukemia [2.85%], MDS [2.85%], malaria [2.85%], hypersplenism 2.85%], lymphoid malignancy [2.85%], focal gelatinous [2.85%], AML [2.85%], megakaryocytic thrombocytopenia [2.85%], and plasma cell myeloma [2.85%].
Conclusion: It was concluded that the detailed hematological investigations, a thorough clinical examination with hematological studies and bone marrow study is important for understanding the disease process and diagnosing the causes of pancytopenia.